Similar results were obtained with ERK1/2 shRNA and doxorubicin, which decreased proliferation in HT1080, SK-LMS-1, and DDLS8817 sarcoma cells by 69–72% (Fig. 5D), and induced apoptosis to a greater degree than either alone (Fig. 5E). This evidence concerns the gene MAPK3 and sarcoma.